ES455620A1 - Un metodo para preparar una 2'-(carboximetoxi)-calcona. - Google Patents

Un metodo para preparar una 2'-(carboximetoxi)-calcona.

Info

Publication number
ES455620A1
ES455620A1 ES455620A ES455620A ES455620A1 ES 455620 A1 ES455620 A1 ES 455620A1 ES 455620 A ES455620 A ES 455620A ES 455620 A ES455620 A ES 455620A ES 455620 A1 ES455620 A1 ES 455620A1
Authority
ES
Spain
Prior art keywords
carboxymethoxy
chalcones
formula
preparing
new
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES455620A
Other languages
English (en)
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Taisho Pharmaceutical Co Ltd
Original Assignee
Taisho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taisho Pharmaceutical Co Ltd filed Critical Taisho Pharmaceutical Co Ltd
Publication of ES455620A1 publication Critical patent/ES455620A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/76—Unsaturated compounds containing keto groups
    • C07C59/90—Unsaturated compounds containing keto groups containing singly bound oxygen-containing groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/68—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
    • C07C45/70—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form
    • C07C45/71—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form being hydroxy groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ES455620A 1976-02-13 1977-02-03 Un metodo para preparar una 2'-(carboximetoxi)-calcona. Expired ES455620A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP1457876A JPS5297950A (en) 1976-02-13 1976-02-13 Chalconeether derivatives

Publications (1)

Publication Number Publication Date
ES455620A1 true ES455620A1 (es) 1978-01-01

Family

ID=11865033

Family Applications (1)

Application Number Title Priority Date Filing Date
ES455620A Expired ES455620A1 (es) 1976-02-13 1977-02-03 Un metodo para preparar una 2'-(carboximetoxi)-calcona.

Country Status (12)

Country Link
US (1) US4085135A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JPS5297950A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AR (1) AR209544A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA1084064A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CH (1) CH605537A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE2705603C2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ES (1) ES455620A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FR (1) FR2340924A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GB (1) GB1523241A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
HU (1) HU173019B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PT (1) PT66118B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
YU (1) YU39378B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4190671A (en) * 1977-03-17 1980-02-26 Biorex Laboratories Limited Chalcone derivatives
JPS5552597U (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) * 1978-09-30 1980-04-08
JPS62207212A (ja) * 1986-03-08 1987-09-11 Nippon Haipotsukusu:Kk 抗アレルギ−剤
US5089654A (en) * 1989-08-08 1992-02-18 Taisho Pharmaceutical Co., Ltd. Chalcone derivatives
AU742787B2 (en) 1997-07-09 2002-01-10 Androsolutions, Inc. Improved methods and compositions for treating male erectile dysfunction
US6103765A (en) * 1997-07-09 2000-08-15 Androsolutions, Inc. Methods for treating male erectile dysfunction
KR20030031500A (ko) * 2000-06-20 2003-04-21 아테로제닉스, 인코포레이티드 1,3-비스-(치환된-페닐)-2-프로펜-1-온 및 ｖｃａｍ-1매개된 질환을 치료하기 위한 그의 용도
AU2002248910A1 (en) 2000-11-17 2002-05-27 Idenix (Cayman) Limited Methods for inhibiting the transmission of HIV using topically applied substituted 6-benzyl-4-oxopyrmidines
HUP0500165A2 (en) * 2001-12-19 2006-09-28 Atherogenics Inc Chalcone derivatives and their use to treat diseases
WO2004056727A2 (en) * 2002-12-19 2004-07-08 Atherogenics, Inc. Process of making chalcone derivatives
US7173129B2 (en) * 2003-06-06 2007-02-06 Athero Genics, Inc. Sulfonamide-substituted chalcone derivatives and their use to treat diseases
WO2006004903A2 (en) * 2004-06-28 2006-01-12 Atherogenics, Inc. 1,2-bis-(substituted-phenyl)-2-propen-1-ones and pharmaceutical compositions thereof
WO2009122435A2 (en) * 2008-03-31 2009-10-08 Council Of Scientific & Industrial Research A simultaneous method for the preparation of a mixture of 3- acetoxy-17-acetamido-16-formyl-androst-5,17-diene and 3- acetoxy-2'-chloro-5-androsteno[17,16-b]pyridine
CN101817741B (zh) * 2009-12-10 2013-10-16 天津药物研究院 索法酮的晶型ⅸ及其制备方法和用途
CN101781194B (zh) * 2009-12-10 2013-05-15 天津药物研究院 索法酮的晶型ⅴ及其制备方法和用途
CN101792385B (zh) * 2009-12-10 2013-05-15 天津药物研究院 索法酮的晶型ⅷ及其制备方法和用途
CN101735038B (zh) * 2009-12-10 2013-06-26 天津药物研究院 索法酮的晶型ⅰ及其制备方法和用途
CN101735040B (zh) * 2009-12-10 2013-05-15 天津药物研究院 索法酮的晶型ⅲ及其制备方法和用途
CN101817742B (zh) * 2009-12-10 2013-10-16 天津药物研究院 索法酮的晶型ⅹ及其制备方法和用途
CN101735039B (zh) * 2009-12-10 2013-06-26 天津药物研究院 索法酮的晶型ⅱ及其制备方法和用途
CN101781195B (zh) * 2009-12-10 2013-03-13 天津药物研究院 索法酮的晶型ⅶ及其制备方法和用途
CN101781193B (zh) * 2009-12-10 2013-05-15 天津药物研究院 索法酮的晶型ⅳ及其制备方法和用途
CN101781192B (zh) * 2009-12-10 2013-05-15 天津药物研究院 索法酮的晶型ⅵ及其制备方法和用途
CN115368265B (zh) * 2022-10-24 2023-03-28 中国中医科学院中药研究所 一种索法酮小分子活性探针及其制备方法和应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3255241A (en) * 1961-01-19 1966-06-07 Merck & Co Inc (2-alkylidene acyl)phenoxy-and (2-alkylidene acyl)phenylmercaptocarboxylic acids
CH593224A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) * 1973-10-30 1977-11-30 Taisho Pharmaceutical Co Ltd

Also Published As

Publication number Publication date
YU39378B (en) 1984-12-31
AU2131077A (en) 1978-01-26
HU173019B (hu) 1979-01-28
CH605537A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1978-09-29
AR209544A1 (es) 1977-04-29
JPS5645896B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1981-10-29
US4085135A (en) 1978-04-18
DE2705603C2 (de) 1986-07-24
FR2340924A1 (fr) 1977-09-09
YU8977A (en) 1982-06-30
GB1523241A (en) 1978-08-31
JPS5297950A (en) 1977-08-17
CA1084064A (en) 1980-08-19
PT66118A (en) 1977-02-01
PT66118B (en) 1978-06-28
DE2705603A1 (de) 1977-08-18
FR2340924B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1979-03-23

Similar Documents

Publication Publication Date Title
ES455620A1 (es) Un metodo para preparar una 2'-(carboximetoxi)-calcona.
NL7708422A (nl) Steriliseerbare verpakking.
DK147104C (da) Fremgangsmaade til fremstilling af hydrogenperoxid
BG28061A3 (en) Method of obtaining of hexahydrodibenzopyranones
BG28060A3 (en) Method of transforming of cis- hexahydrodibenzo (beta,alpha) pyran- 9-ones in trans- hexahydrodibenzo (beta,alpha) pyran- 9- ones
BG32851A3 (bg) Метод за получаване на 3,4,5,6-тетрахидро-2н- -1-бензоксецини
BG28068A3 (bg) Метод за получаване на -3- хлорцефалоспорини
BG28849A3 (bg) Метод за получаване на гамапирони
IT1046877B (it) Trifevil 1.2.3. triazolil i metani procedimento per la loro preparazione e loro impiego come fugicida
BG33295A3 (bg) Метод за получаване на виндезин
IT7922515A0 (it) N,n'-di-(idrossi-fenil) derivati della piperazina e loro impiegocome stabilizzanti per polimeri.
SU520486A1 (ru) Компенсатор преимущественно дл трубопроводов пр моугольного сечени
BG33436A3 (en) Method for obtaining of 4- dezacetyl- vinblastine- 3- spiro- 5"- oxazolidin- 2", 4"- dion
ES446666A1 (es) Un procedimiento para la preparacion de nuevos derivados de 5-fenil-2-furamidoxinicas.
ES462849A1 (es) Un procedimiento para la preparacion de nuevos derivados de 3,5-diona-4,4-dimetil-pirrolidina.
JPS52153947A (en) Dicyclododecyl peroxycarbonate
SE7713700L (sv) 2-substituerade-1-(omega-aminoalkoxi)bensener
BG28058A4 (bg) Метод за получаване на дибензо(в,d)пирани
SU607677A1 (ru) Метчик
SU676662A1 (ru) Отбеливающий состав "диола"
BG31500A3 (en) Method for obtaining of 2/3- arjl- 5- isoxazol/ benzoilhalid
SU544587A1 (ru) Тара дл электровакуумных приборов
ES465216A1 (es) Un procedimiento para la preparacion de d-homoesteroides.
SU547733A2 (ru) Редуктор давлени
SU594236A1 (ru) Трубопроводный переход

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19981103